Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Plasma kinetics of zeaxanthin and 3'-dehydro-lutein after multiple oral doses of synthetic zeaxanthin.
- D. Hartmann, P. Thürmann, V. Spitzer, W. Schalch, Birke Manner, W. Cohn
- Chemistry, Medicine
- The American journal of clinical nutrition
- 1 March 2004
BACKGROUND
Zeaxanthin is hypothesized to reduce the risk of age-related macular degeneration; however, kinetic information is limited.
OBJECTIVES
The objective was to investigate the plasma… Expand
Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor
- J. Borovička, W. Schwizer, +5 authors M. Fried
- Chemistry, Medicine
- Gut
- 1 June 2000
BACKGROUND AND AIMS To investigate the importance of lipase on gastric functions, we studied the effects of orlistat, a potent and specific inhibitor of lipase, on postprandial gastric acidity and… Expand
Role of lipase in the regulation of upper gastrointestinal function in humans.
- W. Schwizer, K. Asal, +6 authors M. Fried
- Chemistry, Medicine
- The American journal of physiology
- 1 September 1997
The role of lipase in the regulation of upper gastrointestinal function is poorly understood. We studied the effect of orlistat, a new, potent, and highly specific lipase inhibitor, on gastric… Expand
On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers.
- A. Kallner, D. Hartmann, D. Hornig
- Chemistry, Medicine
- The American journal of clinical nutrition
- 1 July 1981
The time course of radioactivity in plasma and urine after oral administration of a single dose of (1-14 C) ascorbic acid has been followed in healthy male volunteers smoking more than 20 cigarettes… Expand
On the absorption of ascorbic acid in man.
- A. Kallner, D. Hartmann, D. Hornig
- Biology, Medicine
- International journal for vitamin and nutrition…
- 1977
The daily intake of ascorbic acid with the diet was strongly restricted in seven healthy non-smoking males and 90 to 180 mg of ascorbic acid were orally supplemented. After an equilibration period of… Expand
Steady-state turnover and body pool of ascorbic acid in man.
- A. Kallner, D. Hartmann, D. Hornig
- Medicine
- The American journal of clinical nutrition
- 1 March 1979
The time course of radioactivity in plasma and urine after oral administration of a single dose of (1-14C)ascorbic acid has been followed in healthy nonsmoking male volunteers. The investigation was… Expand
Pharmacokinetics of Digoxin and Main Metabolites/Derivatives in Healthy Humans
- P. Hinderling, D. Hartmann
- Medicine
- Therapeutic drug monitoring
- 1 September 1991
Three healthy, young male volunteers received doses of 0.6 and 1.2 mg of specifically labelled [3H]digoxin each by intravenous (i.v.) bolus injection and oral (p.o.) administration in accordance with… Expand
Absorption of large, single, oral intakes of ascorbic acid.
- D. Hornig, J. P. Vuilleumier, D. Hartmann
- Biology, Medicine
- International journal for vitamin and nutrition…
- 1980
A male non-smoking volunteer increased his daily intake of ascorbic acid continuously by ingesting in a single, oral dose 1, 2, 3, 4 and 5 g crystalline ascorbic acid. The dose was always kept… Expand
The pH Dependency of the Binding of Drugs to Plasma Proteins in Man
- P. Hinderling, D. Hartmann
- Chemistry, Medicine
- Therapeutic drug monitoring
- 1 February 2005
An analysis of pH-induced changes of drug binding may contribute to the understanding of the mechanisms involved and the clinical relevance. A literature search was performed, and acceptance criteria… Expand
Degree of in vivo inhibition of human gastric and pancreatic lipases by Orlistat (Tetrahydrolipstatin, THL) in the stomach and small intestine.
- B. Sternby, D. Hartmann, B. Borgström, A. Nilsson
- Medicine
- Clinical nutrition
- 1 October 2002
BACKGROUND AND AIMS
Orlistat, a lipase inhibitor, strongly inhibits the activities of all gastric/pancreatic lipases except pancreatic phospholipase A(2)in vitro. In clinical use, for obesity… Expand
...
1
2
3
4
5
...